Clinical trial
Weekly Topotecan Therapy in Patients With Ovarian Cancer
NCT00194935 · Weill Medical College of Cornell University, Other · Terminated
Key facts
| NCT number | NCT00194935 |
|---|---|
| Title | Weekly Topotecan Therapy in Patients With Ovarian Cancer |
| Official title | A Phase II Trial of Weekly Topotecan As Consolidation Therapy in Ovarian Cancer Patients After Initial Chemotherapy |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Topotecan |
| Enrollment | 32 |
| Start date | Feb 1, 2003 |
| Completion | Aug 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 13, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: